23 Sep 2011 09:34
RNS Number : 8119O
Immupharma PLC
23 September 2011
For Immediate Release | 23 September 2011 |
ImmuPharma PLC
Notification of Interim Results
Date: 30 September 2011
ImmuPharma PLC (AIM:IMM), the specialist discovery and development pharmaceutical company, is scheduled to announce its Interim Results for the six months ended 30 June 2011 on 30 September 2011.
- Ends -
For further information, please contact:
ImmuPharma PLC | |
Dr Robert Zimmer, President | +33 389 66 13 20 |
Richard Warr, Chairman | +44 20 7152 4080 |
Dimitri Dimitriou, Chief Executive Officer | +44 20 7152 4080 |
| |
Buchanan Communications | + 44 20 7466 5000 |
Lisa Baderoon, Mark Court | |
| |
Panmure Gordon & Co | +44 151 243 0963 |
Andrew Burnett | |
| |
Espirito Santo Investment Bank | +44 20 7456 9191 |
James Bromhead, Richard Crawley |
This information is provided by RNS
The company news service from the London Stock Exchange
Immupharma (IMM)